Actuate Therapeutics, a Phase 2 biotech developing in-licensed inhibitor therapies for difficult to treat cancers, filed on Friday with...

Read more
By: Stephanie Kawecki On: May 14, 2024 In: MemVerge, Portfolio News

MemVerge in collaboration with Micron and SuperMicro showcased a remarkable breakthrough in computing at Nvidia’s GTC conference.  MemVerge demonstrated...

Read more

Vivodyne, a pioneering biotech company that grows and tests on lab-grown human tissues to accelerate therapeutics discovery and development,...

Read more

Clearsense, a PaaS company that partners with healthcare organizations to increase data value, governance, and transparency, today announced it...

Read more
By: Stephanie Kawecki On: April 16, 2024 In: Foldax, Portfolio News

Foldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced that its TRIA valves have...

Read more
By: Stephanie Kawecki On: April 3, 2024 In: Linnaeus, Portfolio News

Linnaeus Therapeutics, Inc., a Kairos portfolio company focused on the development and commercialization of novel small molecule oncology therapeutics, today...

Read more

Sienza Energy, a Caltech-incubated battery company backed by Los Angeles-based philanthropist Dr. Patrick Soon-Shiong and Kairos ventures announced its capacity test...

Read more
By: Stephanie Kawecki On: March 21, 2024 In: Amorphology, Portfolio News

“Amorphology looks forward to its enhanced and optimized partnership with Liquidmetal Technologies, bringing deep materials science and amorphous metals...

Read more
By: Stephanie Kawecki On: March 21, 2024 In: MemVerge, Portfolio News

MemVerge®, a leader in AI-first Big Memory Software, has joined forces with Micron to unveil a groundbreaking solution that...

Read more
By: Stephanie Kawecki On: March 4, 2024 In: Neuro-Bio, Portfolio News

Aptamer Group plc, the developer of novel Optimer binders, announces the second phase of its on-going partnership with Neuro-Bio, an Oxfordshire-based biotechnology...

Read more